-
1 Comment
NanJing Pharmaceutical Company Limited is currently in a long term uptrend where the price is trading 2.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
NanJing Pharmaceutical Company Limited's total revenue rose by 13.5% to $11B since the same quarter in the previous year.
Its net income has increased by 78.3% to $94M since the same quarter in the previous year.
Finally, its free cash flow fell by 67.1% to $948M since the same quarter in the previous year.
Based on the above factors, NanJing Pharmaceutical Company Limited gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| ISIN | CNE000000KV1 |
| Industry | Drug Manufacturers - General |
| Exchange | SHG |
| CurrencyCode | CNY |
| Beta | 0.43 |
|---|---|
| Market Cap | 7B |
| PE Ratio | 11.4 |
| Target Price | 11.6 |
| Dividend Yield | None |
NanJing Pharmaceutical Company Limited engages in the pharmaceutical wholesale and retail businesses in China. It also operates an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600713.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
